aica ribonucleotide has been researched along with Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buhl, ES; Flyvbjerg, A; Jessen, N; Ledet, T; Lund, S; Pedersen, O; Pedersen, SB; Pold, R; Schmitz, O | 1 |
1 other study(ies) available for aica ribonucleotide and Syndrome
Article | Year |
---|---|
Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome.
Topics: 3-O-Methylglucose; Adenylate Kinase; Aminoimidazole Carboxamide; Animals; Blood Glucose; Blood Pressure; Glucose Clamp Technique; Glucose Transporter Type 4; Hypertension; Insulin Resistance; Male; Metabolic Syndrome; Monosaccharide Transport Proteins; Muscle Proteins; Rats; Rats, Zucker; Ribonucleotides; Syndrome | 2002 |